EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MicroRNA and Protein Biomarkers of Intestinal Permeability in the Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Dominika Białek, Ewa Wunsch, Agnieszka Kempińska-Podhorodecka iD, Joanna Abramczyk iD, Adam Wunsch, Katarzyna Kozłowska

International Journal of Molecular Sciences · 24.11.2025 · 26 (23) · 11351

DOI: 10.3390/ijms262311351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.11.2025. Verfasst von Dominika Białek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Pomeranian Medical University, 71-252 Szczecin, Poland. Hauptthemen laut MEDLINE: MicroRNAs, Biomarkers, Fatty Liver, Intestinal Mucosa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, National Science Center, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intestinal barrier dysfunction and microRNA dysregulation are proposed contributors to progression of metabolic dysfunction-associated steatotic liver disease (MASLD). We aimed to assess selected protein and miRNA biomarkers of intestinal permeability in relation to MASLD severity. We included 104 patients with MASLD and 57 healthy controls. Serum lipopolysaccharide-binding protein (LBP), diamine oxidase (DAO), tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and miRNAs (miR-21, miR-29a, miR-122) were measured. Multivariable logistic regression identified independent predictors of steatosis and fibrosis severity. Patients with MASLD showed higher LBP levels (p = 0.002) and increased serum miR-122 expression (p < 0.0001) compared with controls. LBP correlated with CAP values (Rho = 0.23, p = 0.02) and was elevated in advanced steatosis (p = 0.04). DAO levels correlated with CAP (Rho = 0.22, p = 0.02) and were higher in advanced steatosis (p = 0.04) but decreased in advanced fibrosis (p = 0.04). MiR-122 correlated with fibrosis indices (TE: Rho = 0.22, p = 0.03; APRI: Rho = 0.41, p = 0.0001) and liver enzymes (ALT: Rho = 0.40, AST: Rho = 0.50, both p < 0.0001). Logistic regression identified elevated miR-122 and reduced miR-21 as independent predictors of MASLD, while DAO and transaminases predicted advanced steatosis. Elevated serum miR-122, alongside reduced miR-21, independently predict MASLD. DAO is associated with steatosis severity, while miR-122 reflects fibrotic progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBiomarkersFatty LiverIntestinal MucosaHumansMaleFemaleMiddle AgedAdultAmine Oxidase (Copper-Containing)PermeabilityCarrier ProteinsCase-Control StudiesMembrane GlycoproteinsAgedAcute-Phase ProteinsLiver CirrhosisInterleukin-6Tumor Necrosis Factor-alphaIntestinal Barrier FunctionLipopolysaccharide-Binding Protein

Stichwörter der Autor:innen

biomarkersgut barrier dysfunctionmetabolic dysfunction-associated steatotic liver disease (MASLD)microRNA

Substanzen

MicroRNAsBiomarkersAmine Oxidase (Copper-Containing)Carrier ProteinsMembrane GlycoproteinsAcute-Phase ProteinsInterleukin-6Tumor Necrosis Factor-alphaLipopolysaccharide-Binding ProteinMIRN122 microRNA, human

Autor:innen und Institutionen

  • Department of Translational Medicine, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Department of Medical Biology, Pomeranian Medical University, 70-111 Szczecin, Poland.

ORCID-Profile: Agnieszka Kempińska-Podhorodecka, Joanna Abramczyk

Förderung

  • National Science Centre
  • National Science Center, Poland

Zitieren

APA

Białek, D., Wunsch, E., Kempińska-Podhorodecka, A., Abramczyk, J., Wunsch, A., & Kozłowska, K. (2025). MicroRNA and Protein Biomarkers of Intestinal Permeability in the Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). International Journal of Molecular Sciences, 26(23), 11351. https://doi.org/10.3390/ijms262311351

Vancouver

Białek D, Wunsch E, Kempińska-Podhorodecka A, Abramczyk J, Wunsch A, Kozłowska K. MicroRNA and Protein Biomarkers of Intestinal Permeability in the Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). International Journal of Molecular Sciences. 2025;26(23):11351. doi:10.3390/ijms262311351

BibTeX
@article{Biaek2025,
  author = {Białek, Dominika and Wunsch, Ewa and Kempińska-Podhorodecka, Agnieszka and Abramczyk, Joanna and Wunsch, Adam and Kozłowska, Katarzyna},
  title = {MicroRNA and Protein Biomarkers of Intestinal Permeability in the Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {23},
  pages = {11351},
  doi = {10.3390/ijms262311351}
}
Kostenlos starten →